Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Girentuximab> ?p ?o. }
Showing items 1 to 56 of
56
with 100 items per page.
- Girentuximab abstract "Girentuximab (trade name Rencarex) is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.Girentuximab was developed by Wilex AG.".
- Girentuximab atcPrefix "none".
- Girentuximab casNumber "916138-87-9".
- Girentuximab fdaUniiCode "539B57DFJF".
- Girentuximab wikiPageID "33025505".
- Girentuximab wikiPageRevisionID "537846250".
- Girentuximab atcPrefix "none".
- Girentuximab c "6460".
- Girentuximab casNumber "916138".
- Girentuximab chemspiderid "NA".
- Girentuximab h "10006".
- Girentuximab hasPhotoCollection Girentuximab.
- Girentuximab mabType "mab".
- Girentuximab molecularWeight "146.5".
- Girentuximab n "1718".
- Girentuximab o "2018".
- Girentuximab s "48".
- Girentuximab source "xi".
- Girentuximab target Carbonic_anhydrase_9.
- Girentuximab tradename "Rencarex".
- Girentuximab type "mab".
- Girentuximab unii "539".
- Girentuximab verifiedfields "changed".
- Girentuximab verifiedrevid "458274725".
- Girentuximab subject Category:Monoclonal_antibodies.
- Girentuximab type Abstraction100002137.
- Girentuximab type Antibody115027189.
- Girentuximab type Chemical114806838.
- Girentuximab type Compound114818238.
- Girentuximab type Macromolecule114944888.
- Girentuximab type Material114580897.
- Girentuximab type Matter100020827.
- Girentuximab type Molecule114682133.
- Girentuximab type MonoclonalAntibodies.
- Girentuximab type MonoclonalAntibody115029781.
- Girentuximab type OrganicCompound114727670.
- Girentuximab type Part113809207.
- Girentuximab type PhysicalEntity100001930.
- Girentuximab type Protein114728724.
- Girentuximab type Relation100031921.
- Girentuximab type Substance100019613.
- Girentuximab type Thing100002452.
- Girentuximab type Unit109465459.
- Girentuximab type Drug.
- Girentuximab type FunctionalSubstance.
- Girentuximab comment "Girentuximab (trade name Rencarex) is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.Girentuximab was developed by Wilex AG.".
- Girentuximab label "Girentuximab".
- Girentuximab label "Girentuximab".
- Girentuximab label "جيرنتوكسيماب".
- Girentuximab sameAs Girentuximab.
- Girentuximab sameAs m.0h54zbv.
- Girentuximab sameAs Q5564223.
- Girentuximab sameAs Q5564223.
- Girentuximab sameAs Girentuximab.
- Girentuximab wasDerivedFrom Girentuximab?oldid=537846250.
- Girentuximab isPrimaryTopicOf Girentuximab.